Leishmaniasis, Cutaneous
25
2
3
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.0%
1 terminated out of 25 trials
93.8%
+7.2% vs benchmark
16%
4 trials in Phase 3/4
20%
3 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (25)
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.
LEISH-PED: Study on Leishmaniasis in Children
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis
Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL
A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol
Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH)
Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru
Miltefosine Plus IL Pentamidine for Bolivian CL
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis